Nutex Befektetesi Nyrt banner
N

Nutex Befektetesi Nyrt
BET:NUTEX

Watchlist Manager
Nutex Befektetesi Nyrt
BET:NUTEX
Watchlist
Price: 14.8 HUF 5.71% Market Closed
Market Cap: Ft2.3B

Nutex Befektetesi Nyrt
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nutex Befektetesi Nyrt
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
Nutex Befektetesi Nyrt
BET:NUTEX
Revenue
Ft450k
CAGR 3-Years
0%
CAGR 5-Years
-11%
CAGR 10-Years
-54%
R
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
Revenue
Ft929B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
10%
No Stocks Found

Nutex Befektetesi Nyrt
Glance View

Market Cap
2.3B HUF
Industry
Pharmaceuticals

Nutex Befektetesi Nyrt is a HU-based company operating in Pharmaceuticals industry. The company is headquartered in Budapest, Budapest. NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.

NUTEX Intrinsic Value
2.18 HUF
Overvaluation 85%
Intrinsic Value
Price Ft14.8
N

See Also

What is Nutex Befektetesi Nyrt's Revenue?
Revenue
450k HUF

Based on the financial report for Dec 31, 2024, Nutex Befektetesi Nyrt's Revenue amounts to 450k HUF.

What is Nutex Befektetesi Nyrt's Revenue growth rate?
Revenue CAGR 10Y
-54%

Over the last year, the Revenue growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett